Literature DB >> 31861963

Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis.

Nicolás Anselmino1,2, Michael Starbuck3, Estefania Labanca3, Javier Cotignola1,2, Nora Navone3, Geraldine Gueron1,2, Ana C Zenclussen4, Elba Vazquez1,2.   

Abstract

Aims: Bone is the most frequent site of prostate cancer (PCa) metastasis. Tumor cells interact with the bone microenvironment interrupting tissue balance. Heme oxygenase-1 (HO-1; encoded by Hmox1) appears as a potential target in PCa maintaining the cellular homeostasis. Our hypothesis is that HO-1 is implicated in bone physiology and modulates the communication with PCa cells. Here we aimed at (i) assessing the physiological impact of Hmox1 gene knockout (KO) on bone metabolism in vivo and (ii) determining the alterations of the transcriptional landscape associated with tumorigenesis and bone remodeling in cells growing in coculture (PCa cells with primary mouse osteoblasts [PMOs] from BALB/c Hmox1+/+, Hmox1+/-, and Hmox1-/- mice).
Results: Histomorphometric analysis of Hmox1-/- mice bones exhibited significantly decreased bone density with reduced remodeling parameters. A positive correlation between Hmox1 expression and Runx2, Col1a1, Csf1, and Opg genes was observed in PMOs. Flow cytometry studies revealed two populations of PMOs with different reactive oxygen species (ROS) levels. The high ROS population was increased in PMOs Hmox1+/- compared with Hmox1+/+, but was significantly reduced in PMOs Hmox1-/-, suggesting restrained ROS tolerance in KO cells. Gene expression was altered in PMOs upon coculture with PCa cells, showing a pro-osteoclastic profile. Moreover, HO-1 induction in PCa cells growing in coculture with PMOs resulted in a significant modulation of key bone markers such as PTHrP and OPG. Innovation and
Conclusion: We here demonstrate the direct implications of HO-1 expression in bone remodeling and how it participates in the alterations in the communication between bone and prostate tumor cells.

Entities:  

Keywords:  HMOX1; bone remodeling; osteoblasts; osteoclasts; prostate cancer

Mesh:

Substances:

Year:  2020        PMID: 31861963      PMCID: PMC7232646          DOI: 10.1089/ars.2019.7879

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  68 in total

1.  Osteoclasts: what do they do and how do they do it?

Authors:  Steven L Teitelbaum
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  Biomechanical and molecular regulation of bone remodeling.

Authors:  Alexander G Robling; Alesha B Castillo; Charles H Turner
Journal:  Annu Rev Biomed Eng       Date:  2006       Impact factor: 9.590

Review 3.  Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.

Authors:  Theresa A Guise; Khalid S Mohammad; Gregory Clines; Elizabeth G Stebbins; Darren H Wong; Linda S Higgins; Robert Vessella; Eva Corey; Susan Padalecki; Larry Suva; John M Chirgwin
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

4.  Osteoblast isolation from murine calvaria and long bones.

Authors:  Astrid D Bakker; Jenneke Klein-Nulend
Journal:  Methods Mol Biol       Date:  2012

5.  Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation.

Authors:  Jianwen Wei; Junko Shimazu; Munevver P Makinistoglu; Antonio Maurizi; Daisuke Kajimura; Haihong Zong; Takeshi Takarada; Takashi Lezaki; Jeffrey E Pessin; Eiichi Hinoi; Gerard Karsenty
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

Review 6.  Haem oxygenase-1: non-canonical roles in physiology and pathology.

Authors:  Anna Grochot-Przeczek; Jozef Dulak; Alicja Jozkowicz
Journal:  Clin Sci (Lond)       Date:  2012-02       Impact factor: 6.124

Review 7.  Osteoclast-osteoblast communication.

Authors:  Koichi Matsuo; Naoko Irie
Journal:  Arch Biochem Biophys       Date:  2008-03-29       Impact factor: 4.013

8.  Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.

Authors:  Hiroyuki Yonou; Atsushi Ochiai; Masato Goya; Naoki Kanomata; Sanehiro Hokama; Makoto Morozumi; Kimio Sugaya; Tadashi Hatano; Yoshihide Ogawa
Journal:  Prostate       Date:  2004-03-01       Impact factor: 4.104

Review 9.  Role of osteoprotegerin (OPG) in cancer.

Authors:  Ingunn Holen; Claire M Shipman
Journal:  Clin Sci (Lond)       Date:  2006-03       Impact factor: 6.124

10.  Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice.

Authors:  Toyokazu Miki; Seiji Yano; Masaki Hanibuchi; Takanori Kanematsu; Hiroaki Muguruma; Saburo Sone
Journal:  Int J Cancer       Date:  2004-02-10       Impact factor: 7.396

View more
  6 in total

1.  12-Deoxyphorbol-13-Hexadecanoate Abrogates OVX-Induced Bone Loss in Mice and Osteoclastogenesis via Inhibiting ROS Level and Regulating RANKL-Mediated NFATc1 Activation.

Authors:  Qi He; Junzheng Yang; Delong Chen; Yejia Li; Dawei Gong; Hui Ge; Zihao Wang; Haibin Wang; Peng Chen
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 2.  HO-1 in Bone Biology: Potential Therapeutic Strategies for Osteoporosis.

Authors:  Xueman Zhou; Wenxiu Yuan; Xin Xiong; Zhenzhen Zhang; Jiaqi Liu; Yingcheng Zheng; Jun Wang; Jin Liu
Journal:  Front Cell Dev Biol       Date:  2021-11-30

Review 3.  Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer.

Authors:  YouZhi Wang; Ning Wu; Ning Jiang
Journal:  Cell Death Dis       Date:  2021-10-05       Impact factor: 8.469

4.  HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer Progression.

Authors:  Nicolás Anselmino; Juan Bizzotto; Pablo Sanchis; Sofia Lage-Vickers; Emiliano Ortiz; Pia Valacco; Alejandra Paez; Estefania Labanca; Roberto Meiss; Nora Navone; Javier Cotignola; Elba Vazquez; Geraldine Gueron
Journal:  Biomolecules       Date:  2020-03-18

5.  TNFRSF11B activates Wnt/β-catenin signaling and promotes gastric cancer progression.

Authors:  Fengming Luan; Xiaomei Li; Xiaojing Cheng; Longtao Huangfu; Jing Han; Ting Guo; Hong Du; Xianzi Wen; Jiafu Ji
Journal:  Int J Biol Sci       Date:  2020-04-25       Impact factor: 6.580

Review 6.  Heme oxygenase 1: a novel oncogene in multiple gynecological cancers.

Authors:  Jia-Jing Lu; Ayitila Abudukeyoumu; Xing Zhang; Li-Bing Liu; Ming-Qing Li; Feng Xie
Journal:  Int J Biol Sci       Date:  2021-06-01       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.